Growth Metrics

Healthequity (HQY) Capital Expenditures (2016 - 2026)

Healthequity has reported Capital Expenditures over the past 14 years, most recently at -$1.6 million for Q1 2026.

  • For Q1 2026, Capital Expenditures rose 4.91% year-over-year to -$1.6 million; the TTM value through Jan 2026 reached $16000.0, down 64.44%, while the annual FY2026 figure was $16000.0, 64.44% down from the prior year.
  • Capital Expenditures for Q1 2026 was -$1.6 million at Healthequity, down from $784000.0 in the prior quarter.
  • Over five years, Capital Expenditures peaked at $42.2 million in Q1 2023 and troughed at -$23.6 million in Q4 2024.
  • A 5-year average of $5.1 million and a median of $935000.0 in 2022 define the central range for Capital Expenditures.
  • Biggest five-year swings in Capital Expenditures: soared 4413.58% in 2023 and later plummeted 11569.8% in 2024.
  • Year by year, Capital Expenditures stood at $2.6 million in 2022, then tumbled by 107.72% to -$202000.0 in 2023, then plummeted by 11569.8% to -$23.6 million in 2024, then skyrocketed by 103.33% to $784000.0 in 2025, then tumbled by 307.53% to -$1.6 million in 2026.
  • Business Quant data shows Capital Expenditures for HQY at -$1.6 million in Q1 2026, $784000.0 in Q4 2025, and -$15.2 million in Q3 2025.